be used by trained personnel. Inspect the vaccination site 6 to 8 days after vaccination and interpret the response as follows:
1. A primary vaccination, if successful, shows a typical vesicle. If none is observed, check the vaccination procedures and repeat the vaccination with another lot of vaccine until a successful result is obtained. Record reactions as successful or unsuccessful.
2. Following revaccination, two possible responses may be noted:
Major reactionA vesicular or pustular lesion, or an area of definite palpable induration or congestion surrounding a central lesion, which may crust or ulcer. This reaction indicates that virus multiplication has most likely taken place and that the revaccination is successful.
Equivocal reactionAny other reaction should be regarded as equivocal. These responses may be the consequence of immunity adequate to suppress virus multiplication or may represent only allergic reactions to an inactive vaccine. If an equivocal reaction is observed, recheck the revaccination procedures and repeat the revaccination one time.
The typhoid vaccine consists of one 0.5 ml dose which is given subcutaneously. The vaccine will be administered to all active duty personnel at their first permanent duty station. Alert Forces will be revaccinated every 3 years. Never give the typhoid vaccine intradermally.
The basic series consists of two 0.5 ml primary injections, given intramuscularly 1 to 2 months apart. A third reinforcing injection of 0.1 ml is given approximately 12 months after the second dose when there is reliable evidence that the person has never received the immunization prior to entering the service. Reimmunization is required every 10 years or may be ordered after a serious injury or burn.
This live trivalent vaccine is given orally either in distilled unchlorinated water, in simple syrup, or by a sterile medicine dropper. Keep the vaccine frozen until needed and use only for 7 days after the bottle is opened. Never refreeze the vaccine. Give a single dose of trivalent oral poliovirus vaccine to all recruits or officers who have not had it within 3 days of recruit training or during officer indoctrination programs.
The influenza virus vaccine must be given annually, at the start of the respiratory disease season (usually October in the northern hemisphere), to all recruits, officer candidates, midshipmen, and members of the Navy and Marine Corps. The vaccine is sometimes offered to other personnel and dependents on a voluntary basis. All active duty Navy and Marine Corps personnel are designated to receive the immunization. Unless otherwise specified, give one injection of 0.5 ml intramuscularly.
This vaccine is given to all Navy and Marine Corps Personnel and also to all other DOD personnel who must travel to a yellow fever endemic area. A single 0.5 ml injection is given subcutaneously. If the vaccine is received in concentrated form, it must be diluted in a 1:10 ratio. Reimmunization is required every 10 years.
This vaccine will only be given on a case by case basis to personnel who must travel to countries still requiring the vaccine. A 0.5 ml dose given either subcutaneously or intramuscularly is required. Reimmunization, if required, will be given at 6-month intervals.
The basic series of plague vaccine consists of two doses. The first is 0.5 ml given intramuscularly and the second is 0.2 ml given intramuscularly 3 months after the first dose. This vaccine is given to all Navy personnel assigned to operational billets with the Fleet Marine Forces. It may be given under special circumstances in very high plague endemic areas or for high risk